DC8779 |
Glycopyrrolate
Featured
|
Glycopyrrolate(Glycopyrronium Br) is a muscarinic competitive antagonist used as an antispasmodic. |
|
DC11454 |
Gly-Pro-pNA
Featured
|
Gly-Pro-pNA is a chromogenic substrate that can be cleaved by the circulating enzyme, dipeptidyl peptidase IV (DPP IV). |
|
DC10874 |
GlyT2-IN-1(YODA 1)
Featured
|
GlyT2-IN-1(YODA 1) is a glycine transporters GLYT2 inhibitor. |
|
DC7135 |
GM6001 (galardin, ilomastat)
Featured
|
GM6001 (galardin, ilomastat) is a broad spectrum MMPs inhibitor for MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MMP-14, and MMP-26 with Ki of 0.4-27 nM. |
|
DC7418 |
DNL201
Featured
|
GNE0877 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitor with an IC50 of 3 nM. |
|
DC10907 |
GNE-131
Featured
|
GNE-131 is a novel NaV1.7 inhibitor with IC50 0.003uM,improving metabolic stability,efficacy in mouse IEM model at C-plasma <2.8uM. |
|
DC8410 |
GNE-317
Featured
|
GNE-317 is a potent, brain-penetrant PI3K inhibitor. |
|
DC10106 |
GNE-3511
Featured
|
GNE-3511 is a potent and selective zipper kinase (DLK, MAP3K12) inhibitors. |
|
DC8257 |
GNE 477
Featured
|
GNE-477 is a potent and efficacious dual PI3K/mTOR inhibitor with IC50 of 4 nM for PI3Kα, Kiapp is 21 nM for mTOR. |
|
DC8502 |
GNE-490
Featured
|
GNE-490 is a highly selective pan-PI3K inhibitor and demonstrates selectivity over mTOR. |
|
DC7953 |
GNE-493
Featured
|
GNE-493 is a potent, selective, and orally available dual pan-PI3K/mTOR inhibitor with IC50s of 3.4/12/16/16/32 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ/mTOR respectively. |
|
DC10546 |
GNE-495
Featured
|
GNE-495 is a potent and Selective MAP4K4 Inhibitor with IC50 of 3.7 nM. |
|
DC26078 |
GNE-616
Featured
|
GNE-616 (GNE616) is a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7 with Ki of 0.79 nM (hNav1.7). |
|
DC10096 |
GNE-617
Featured
|
GNE-617 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with IC50 value of 5nM. |
|
DC12495 |
GNE-6640
Featured
|
GNE-6640 is a potent, selective USP7 inhibitor with IC50 of 0.75 uM; dislpalys selectivity over USP47 and USP5 (IC50>200 uM). |
|
DC11555 |
GNE-6776
Featured
|
GNE-6776 is a novel potent, specific, non-covalent, orally bioavailable USP7 inhibitor with IC50 of 1.34 uM . |
|
DC11729 |
GNE-781
Featured
|
GNE-781 is a potent, selective, non-CNS penetrant, orally active CBP/p300 bromodomain inhibitor with IC50 of 0.94/1.2 nM in TR-FRET assays. |
|
DC7419 |
GNE-7915
Featured
|
GNE-7915 is a highly potent, selective, and brain-penetrable LRRK2 small molecule inhibitor with IC50 of 9 nM in cellular LRRK2 assay; > 100 fold selectivity against a panel of 187 kianses(Ki). |
|
DC26024 |
GNE-8324
Featured
|
GNE-8324 is a potent and selective NMDA receptor PAM. |
|
DC7629 |
GNE-9605
Featured
|
GNE-9605 is a highly potent and selective Leucine-rich repeat kinase 2 (LRRK2) inhibitor |
|
DC1062 |
GNF-2
Featured
|
GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, inhibiting the proliferation of the Bcr-Abl-expressing cells with IC50 of 138 nM. |
|
DC7420 |
GNF-5
Featured
|
GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, is a selective non-ATP competitive inhibitor of Bcr-Abl with an IC50 value of 0.22±0.1 uM (Wild type Abl). |
|
DC7136 |
GNF-5837
Featured
|
GNF-5837 is a potent pan-Trk inhibitor which display antiproliferative effects in cellular Ba/F3 assays (IC50 values are 7, 9 and 11 nM for cells containing the fusion proteins Tel-TrkC, Tel-TrkB and Tel-TrkA, respectively). |
|
DC9285 |
GNF-7
Featured
|
GNF-7 is a potent type-II kinase Bcr-Abl inhibitor with IC50 of <5 nM, 61 nM, 122 nM, 136 nM, and 133 nM for M351T, T315I, E255 V, G250E, and c-Abl, respectively. |
|
DC7660 |
Go 6983
Featured
|
Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively; less potent to PKCζ and inactive to PKCμ. |
|
DC22100 |
GO289
Featured
|
GO289 (GO-289, GO 289) is a potent and selective inhibitor of casein kinase 2 (CK2) with IC50 of 7 nM in in vitro kinase assays, shows minor effects on CKIδ and CKIα activity in vitro. |
|
DC20393 |
Golgicide A
Featured
|
Golgicide A is a potent, highly specific, reversible inhibitor of the cis-Golgi ArfGEF GBF1, inhibits the effect of shiga toxin on protein synthesis with IC50 of 3.3 uM. |
|
DC26017 |
Golotimod (SCV-07)
Featured
|
Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. |
|
DC23028 |
Gomisin A
Featured
|
Gomisin A has anti-inflammatory, antihypertensive, neuroprotective, and anti-proliferation properties, it induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal tran |
|
DC12542 |
GOT1 inhibitor 2c
Featured
|
GOT1 inhibitor 2c is a first-in-class, non-covalent inhibitor of glutamate oxaloacetate transaminase 1 (GOT1) with IC50 of 8.2 uM.. |
|